openPR Logo
Press release

Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ever more prevalent all over the globe will Boost the Antihypertensive Drugs Market's Growth

02-10-2022 02:23 PM CET | Health & Medicine

Press release from: Evolve Business Intelligence

Global Antihypertensive Drugs Market Study Analysis:

The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis and treatment are required. Furthermore, hypertension may cause cardiovascular, renal, or endocrine disorders. Antihypertensive drugs are used to treat hypertension. Hypertension is caused due to unhealthy diets that include excessive salt consumption, a diet high in saturated fat and trans fats, and low intake of fruits and vegetables, physical inactivity, consumption of tobacco and alcohol, and being overweight or obese. Some common antihypertensive drugs available are cardiovascular, renal, or endocrine disorders. These drugs are a combination of several compounds that prevent, control or treat hypertension by reducing cardiovascular morbidity and mortality. According to World Health Organization’s report, there are 1.13 billion people worldwide suffering from hypertension. The increasing geriatric population, changing lifestyle, and rise in population are expected to drive the antihypertensive market growth.

To request a free sample, Go To: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006883

Global Antihypertensive Drugs Drivers And Restrain:
The major factors that have impacted the growth of the antihypertensive drugs market are increasing investments for research for more effective antihypertensive drugs, and the adoption of combination therapies that will enhance the capacity of antihypertensive drugs, among others.

Increasing investments for research:
Hypertension results in various other health issues like kidney diseases, narrowed blood vessels in the eyes, and metabolic syndromes. The available medicines for hypertension are not much effective and have various side effects due to the complications associated with uncontrolled high blood pressure According to World Health Organization 1 in 5 people have the hypertension problem under control and also hypertension is one of the major causes of premature death worldwide. This data states that there is a requirement for better drugs for curing hypertension. Thus, the governments and private drug manufacturers are undertaking a significant amount of R&D investments to discover novel antihypertensive drugs that can treat hypertension with better efficiency than the available drugs. The rise in continual research in this field will thus be anticipated to contribute towards the anti-hypertension market growth in the coming years.

Adoption of Combination Therapies:
The use of a combination of two or more antihypertensive drugs to cure hypertension is expected to be the most prominent medication type. The combination medicines will prove efficient in patients who have fluctuating blood pressure or are at a higher cardiovascular risk to attain the desirable outcome and reduce the risk of other side effects. The benefits of combination therapy include greater efficacy, improved response rates, better tolerability, favorable pharmacokinetics, improved compliance, and possibly low cost. Several research in the area of combination therapies in the antihypertensive drugs market is likely to increase to achieve therapeutic goals.
The market is hampered by blockbuster medication patents are running out.

Impact Of COVID-19 on the Antihypertensive Drugs Market:
• Impact on Market Size
• End-User Trend, Preferences, and Budget Impact
• Regulatory Framework/Government Policies
• Key Players Strategy to Tackle Negative Impact
• Opportunity Window

Global Antihypertensive Drugs Market Segments:
The global Antihypertensive Drugs market is further segmented into type, product, distribution channel, and geography.
By Therapeutic Class: Diuretics, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Alpha Blockers, Renin Inhibitors, Calcium Channel Blockers, and Others
By Type: Primary Hypertension, and Secondary Hypertension

By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, and Online Stores
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa and South America)

North America is anticipated to dominate the antihypertensive drugs market growth owing to an increasing number of patients with hypertension and a rise in the geriatric population. Moreover, the government and health organization are running various programs for spreading awareness hypertension and presence of advanced healthcare infrastructure are also expected to supplement the antihypertensive drugs market growth in this region. Asia-Pacific is estimated to significantly contribute to the antihypertensive drugs market due to rising awareness towards the use of antihypertensive drugs and the emerging life sciences industry.

Key Players of Global Antihypertensive Drugs Market:
• AstraZeneca
• Johnson & Johnson Services Inc
• Merck & Co Inc
• Novartis
• Pfizer Inc
• Sanofi
• Bayer
• Cipla
• Daiichi Sankyo Company
• Boehringer Ingelheim

For Any Query or Customization, Ask Our Industry Experts@https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006883

Key Questioned Answered Through The Report:
• The Impact of COVID-19 on the global market
• What are the potential opportunities for new entrants in the global market
• What is the market Size and Forecast from 2020 to 2028?
• Key Players associated with the global Antihypertensive Drugs Market
• Value Chain Analysis of Global Antihypertensive Drugs Market
• What is the CAGR of the global Antihypertensive Drugs Market from 2021 to 2028
• Major Growth Factor, Challenges, Trends, and Opportunities in the global market
• Key outcomes of SWOT Analysis

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advising service that offers creative solutions to a company's problems. Data beneficial to micro, small, medium, and large-scale businesses can be found in our market research studies. We offer a wide range of services, from data collection to business consulting.
Evolve Business Intelligence is built on account of technology advancement and our in-house AI-modelled data analysis and forecast tool – EvolveBI – provides extremely accurate data. This application tracks real-time statistics from Fortune's Global 2000 firms, including quarterly performance, annual performance, and recent changes.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ever more prevalent all over the globe will Boost the Antihypertensive Drugs Market's Growth here

News-ID: 2549823 • Views:

More Releases from Evolve Business Intelligence

3D Camera Market Growth Factors, Segmentation, Trends, Opportunities, Key Players and Forecast | Evolve Business Intelligence
3D Camera Market Growth Factors, Segmentation, Trends, Opportunities, Key Player …
As per the study initiated by Evolve Business Intelligence, the global 3D Camera Market size accounted for USD 9.2 Billion in 2022, growing at a CAGR of 31.9% from 2023 to 2033. 3D camera market refers to the market segment that involves the production, sale, and utilization of cameras designed to capture three-dimensional (3D) images or videos. These cameras are equipped with technologies that allow them to record depth information
Air Pressure Therapy Market Key Players | Bio Compression Systems Inc., Tactile Medical, Paul Hartmann AG
Air Pressure Therapy Market Key Players | Bio Compression Systems Inc., Tactile …
As per the study initiated by Evolve Business Intelligence, the global Air Pressure Therapy Market size accounted for USD 4.4 Billion in 2022, growing at a CAGR of 6.5% from 2023 to 2033. Air Pressure Therapy refers to a medical treatment that involves the use of pressurized air to address various health conditions. This can include therapies such as pneumatic compression therapy, which is commonly used for conditions like lymphedema,
Battery Materials Market Key Players | 3M, BASF SE, Celgard LLC
Battery Materials Market Key Players | 3M, BASF SE, Celgard LLC
As per the study initiated by Evolve Business Intelligence, the global Battery Materials Market size accounted for USD 31.3 Billion in 2022, growing at a CAGR of 8.7% from 2023 to 2033. The Battery Materials Market refers to the industry that produces and supplies materials used in the manufacturing of batteries. Batteries are essential components in various electronic devices, electric vehicles, and renewable energy storage systems. The materials used in
Bilirubin Colorimeter Assay Market: The global market is expected to grow at a CAGR of 5.8% during the forecasted period.
Bilirubin Colorimeter Assay Market: The global market is expected to grow at a C …
As per the study initiated by Evolve Business Intelligence, the global Bilirubin Colorimeter Assay Market size accounted for USD 116.8 Million in 2022, growing at a CAGR of 5.8% from 2023 to 2033. The Bilirubin Colorimeter Assay Market is the market for devices and tests used to measure the level of bilirubin in the blood. Bilirubin is a yellow pigment produced by the breakdown of red blood cells. It is

All 5 Releases


More Releases for Antihypertensive

Antihypertensive Drugs Market Segments, Leading Player, Application and Forecast …
Antihypertensive Drugs Market Outlook 2031 • The global antihypertensive drugs market was valued at US$ 30.2 Bn in 2021 • The global market is projected to grow at a CAGR of 3.0% from 2022 to 2031 • The global antihypertensive drugs market is anticipated to reach more than US$ 40 Bn by the end of 2031 Analysts' Viewpoint on Antihypertensive Drugs Market Scenario Increase in launch of new drugs and diagnostic agents; and key industry developments such as
Antihypertensive Drugs Market Report 2021-2031 : Newly Published By Visiongain.
Forecasts By Drug (Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers and Others), By Condition (Primary Hypertension and Secondary Hypertension), By Medication type (Monotherapy, Combination Therapy and Fixed Dose Combinations), By Drug Type (Generic Drugs and Branded Drugs), By Patient Demographics (Geriatric Patient, Adult Patient and Pediatric), By End-User (Hospitals, Homecare, Specialty Clinics and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy,
Antihypertensive Drugs Market Growth, Industry Analysis, Trends and Forecast - 2 …
Antihypertensive Market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2025, registering a CAGR of 3% from 2019 to 2025. Antihypertensive drugs are used in the treatment of hypertensive patients. High blood pressure is a medical condition that involves elevated blood pressure in the arteries. Additionally, patients suffering from high blood pressure are very susceptible to other complications such as heart failure and aneurysms. Therefore,
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best
Antihypertensive Drugs Market Growth and Forecast 2015 - 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to
Antihypertensive Drugs Market : Opportunities and Forecasts upto 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to